Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: August 2, 2012
Reporting Period: The filing announces financial results for the three and six months ended June 30, 2012.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, the filing text does not provide clear values for these metrics.
Material Changes
No material changes or comparative financial data are disclosed within the text of this specific filing. The document serves solely to notify the SEC of the issuance of the press release containing the results.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference a press release issued on August 2, 2012, which contains the operational results and likely management commentary.
Risks and Contingencies: The text includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual revenue, net income, and cash flow figures for the periods ended June 30, 2012.
- Verify year-over-year comparisons and margin trends in the referenced press release.
- Check for any forward-looking statements or guidance included in the press release.
- Confirm the status of the company's liquidity and debt obligations as detailed in the full financial report.